Welcome to our dedicated page for DARKIRIS news (Ticker: DKI), a resource for investors and traders seeking the latest updates and insights on DARKIRIS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DARKIRIS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DARKIRIS's position in the market.
DarkIris (Nasdaq: DKI) received a Nasdaq deficiency letter dated November 18, 2025, notifying the company that its 30-business-day closing bid from October 7, 2025 to November 17, 2025 fell below the $1.00 minimum bid price required by Nasdaq Listing Rule 5550(a)(2).
The Notice does not have an immediate effect on listing and gives DarkIris a 180-calendar-day cure period until May 18, 2026 to regain compliance (or earlier if the share price reaches $1.00 for 10 consecutive business days). If needed, the company may seek a second 180-day extension by meeting Nasdaq market-value and other initial listing standards and, if required, effecting a reverse stock split. The company said operations are unaffected but warned there is no assurance it will regain compliance.
DarkIris (NASDAQ:DKI), a mobile digital gaming technology company, has successfully completed its initial public offering. The company issued 1,725,000 Class A ordinary shares at $4.00 per share, including the full exercise of the underwriters' over-allotment option.
The IPO generated gross proceeds of $6.90 million and began trading on the Nasdaq Capital Market on August 8, 2025. The net proceeds will fund operations team expansion, product development, and working capital. US Tiger Securities served as the sole book runner for this firm commitment offering.
DarkIris (NASDAQ:DKI), a mobile digital gaming technology company, has announced the pricing of its Initial Public Offering (IPO) of 1,500,000 Class A ordinary shares at $4.00 per share. The company expects to raise $6.00 million in gross proceeds from the offering.
Trading is set to commence on August 8, 2025, on the Nasdaq Capital Market under the symbol "DKI". The underwriters have a 45-day option to purchase up to 225,000 additional shares. The IPO proceeds will fund operations team expansion, product development, and working capital. US Tiger Securities is serving as the sole book runner for this firm commitment offering.